高效液相色谱-三重四极杆/复合线性离子阱质谱法测定厄贝沙坦中的基因毒性杂质

    Determination of Genotoxic Impurities in Irbesartan by High Performance Liquid Chromatography-Triple Quadrupole/Composite Linear Ion Trap Mass Spectrometry

    • 摘要:
      目的  建立抗高血压药厄贝沙坦中2-氰基-4’-溴甲基联苯和2-氰基-4’,4’-二溴甲基联苯2种基因毒性杂质的高效液相色谱-三重四极杆/复合线性离子阱质谱分析方法。
      方法 样品经溶剂溶解后,以Agilent Eclipse XDB-C18(2.1 mm×100 mm,3.5 μm)色谱柱分离,梯度洗脱,洗脱液以多反应监测触发增强子离子扫描模式检测,采用二级质谱图进行定性,外标法定量。
      结果 2种基因毒性杂质检出限和定量限分别为0.5和1.0 mg·kg−1,在1~20 μg·L−1内线性关系良好(R2>0.999),在1、5、10 μg·L−1 3个加标浓度下,平均回收率为90%~110%,RSD<5%。
      结论 该方法操作简便,定性定量准确,能够满足厄贝沙坦中2种基因毒性杂质的分析需求。

       

      Abstract:
      OBJECTIVE  To establish a high performance liquid chromatography-triple quadrupole/composite linear ion trap mass spectrometry method of two genotoxic impurities, 2-cyano-4’-bromomethyl biphenyl and 2-cyano-4’,4’-bisbromomethyl biphenyl, in the antihypertensive drug irbesartan.
      METHODS  After solvent dissolution, the samples were separated by Agilent Eclipse XDB-C18 column(2.1 mm×100 mm, 3.5 μm), eluted in gradient, and the eluate was detected by multiple reaction monitoring trigger enhancer ion scanning mode, qualitatively by second-level mass spectrometry and quantified by external standard.
      RESULTS The detection and quantification limits of the two genotoxic impurities were 0.5 and 1.0 mg·kg−1, respectively, with good linear relationship between 1−20 μg·L−1(R2>0.999), at 1, 5 and 10 μg·L−1, the average recovery was between 90% and 110%, and the RSD was <5%.
      CONCLUSION  The established method is easy to operate, accurate in qualitative and quantitative analysis, and can meet the analysis needs of the two genotoxic impurities in irbesartan.

       

    /

    返回文章
    返回